Please login to the form below
biologic
This page shows the latest biologic news and features for those working in and with pharma, biotech and healthcare.
With Spiriva under pressure, Boehringer moves to bolster pipeline
In theory, that could allow drugs to be given at a lower dose – potentially reducing side effects – without compromising their biologic activity.
Latest news
-
Catalent preps for complex therapy boom with $1.2bn Paragon buy
It is predicting sales of around $200m in 2019. That’s tiny in comparison to Catalent’s near $2.5bn in revenues last year from the sale of softgel capsules, biologics ... Paragon brings to Catalent a complementary capability that will fundamentally
-
Merck KGaA exec takes top job at UK biotech Kymab
Mr. Sturge had previously served as SVP, Biopharmaceuticals at Boehringer Ingelheim, overseeing its global biosimilar portfolio, as well as an earlier CEO role at Celltech Biologics.
-
Gottlieb signs off with flair – and pledge of further drug price commentary
market. The FDA now aims to switch insulin products to the Public Health Service Act, which governs most FDA biologic product approvals, a move that should create a more robust approval
-
Takeda’s Entyvio tops Humira in ulcerative colitis
This landmark study raises the question of the optimal biologic for first-line therapy in patients with moderate to severely active ulcerative colitis.”. ... physicians’ treatment decisions when initiating biologic therapy,” said Takeda’s medical
-
Riva leaves Gilead to head Glenmark’s innovation spin-off
The new company's global locations include two R&D centres in Switzerland, its R&D centre in Mahape, Navi Mumbai, India and the GMP biologics manufacturing facility in Switzerland, with
More from news
Approximately 18 fully matching, plus 528 partially matching documents found.
Latest Intelligence
-
Brain power: fresh approaches to Alzheimer’s drug discovery
These trials aim to accommodate phase 2-ready small molecule or biologic candidates.
-
NHS regional footprints
biologics and joint replacement.
-
Is China ready for a pharmaceutical gold rush?
On top of that, several local firms including Junshi Biosciences, Innovent Biologics and Hengrui Medicine, are developing their own PD-1 I-O treatments that are expected to hit the market ... Innovent Biologics Inc raised HK$3.3bn ($421m) at a valuation
-
AstraZeneca’s oncology renaissance
Imfinzi, competing in the hypercompetitive world of immuno-oncology, was developed by MedImmune, the company’s US-based biologics research division, while the two small molecule drugs were developed in the ... The third area is immuno-oncology (IO)
-
Deal Watch October 2018
non‐biologic product post‐patent loss, highlighting the benefits of biologics in the long term and the complexities of developing and manufacturing them. ... $307m. Samsung Bioepis/. Merck &Co. Lusduna Nexvue follow‐on biologic. Termination. $155m.
More from intelligence
Approximately 2 fully matching, plus 74 partially matching documents found.
Latest appointments
-
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO
Bahija has more than 25 years of international leadership experience within the pharmaceutical industry, and joins Immunocore from AstraZeneca, where she has served as President of MedImmune, its global biologics research ... A champion for science and
-
BMS appoints new commercial leader, Davies joins Eisai and more
Commenting on her appointment, Schuermans said: “Sobi has unique capabilities, a heritage in biologics manufacturing, development and supply, and a very exciting future within the rare disease space.
-
Industry appointments
Most recently, Hassan built the oncology-focused biology, preclinical and biomarker units for Immunocore, overseeing early development and the first-in-human trial of a TCR based biologic targeting a melanoma
-
Nabriva Therapeutics appoints chief medical officer
medical affairs for small molecules and biologics.
-
Ipsen appoints Aidan Murphy as EVP, technical operations
He is promoted from senior VP biologics development and manufacturing. Ipsen has added to its executive leadership team in the form of Aidan Murphy, who becomes the biopharma’s executive vice ... being senior vice president biologics development and
More from appointments
Approximately 7 fully matching, plus 46 partially matching documents found.
Latest from PMHub
-
Infographic: Rheumatoid arthritis (RA)
An overview of the RA biologic patient. Our RA market snapshot offers an introduction to the real world patient data collected by our Therapy Watch RA study.
-
Parachuting Behind Enemy Lines: OncoSec’s Attack on Visceral Tumors via Its New Visceral Lesion Applicator (VLA)
It is easy to perform and is more rapid than traditional chemical or biologic cell transfection techniques. ... does not negatively alter the biologic structure or function of the target cells.
-
News: Therapy Watch launches a new wave of EU tracking in Psoriasis (PsO)
A panel of 40 dermatologists in each of the major EU markets reports on patients on advanced therapies including biologics and small molecule therapies every quarter.
-
NHS medicines optimisation milestone
Consequently, it is hugely significant to the NHS’s best value biologics agenda. ... A key issue to consider in this regard is how patients receive biologic medications.
-
OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months. The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and
More from PMHub
Approximately 7 fully matching, plus 36 partially matching documents found.
Featured jobs
-
Senior Medical Writer
-
Salary TBC
-
Director – Healthcare PR
-
Salary TBC
- Editor – Medical Education Agency – Bucks
-
Salary TBC
- Senior Account Director/ Associate Director- Pharma and Life Sci...
-
Competitive salary and benefits
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Senior / Principal Medical Writer - MedComms - Home Based / Vari...
-
Excellent Remuneration Packages
- Experienced / Senior Account Director - Publications - London
-
Up to £80, 000 plus great benefits
- Project Manager - Digital Healthcare - London
-
Excellent Remuneration Package
- Account Director – London based Medical Communications Agency
-
Excellent Remuneration Package
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Senior Account Manager- Pharma and Life Scienes
-
Competitive salary and benefits
-
Account Director, Medical Education
-
Salary TBC
-
Senior Medical Writer
-
Competitive salary and benefits
- Account Manager / Senior Account Manager - Healthcare Advertisin...
-
Excellent Remuneration
- Freelance Medical Writer - Healthcare Advertising - London
-
Employment Type:. Type of Job:. Region:. Salary:. 250 to 330 per day
- Project Manager - Medical Communications – South Wales
-
Excellent Remuneration Package
Subscribe to our email news alerts
- With Spiriva under pressure, Boehringer moves to bolster pipeline
- Genfit claims FDA breakthrough status for liver disease drug
- Mereo’s shareholders back OncoMed takeover
- Lucid Group announces the appointment of new CFO
- From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
- Q&A: Niels Lund
PMHub
Four Health Communications
Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...
Latest intelligence
- From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
- How pharma is progressing their commitment in patient engagement...
- Cuttsy+Cuttsy awarded CPD Platinum by the IPA
- Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
- Breaking Bad
- Six behaviours separate the good brand teams from the bad...
Quick links
Infographics
